The Risk and Prevention of Novel Coronavirus Pneumonia Infections Among Inpatients in Psychiatric Hospitals  

作　　者：Yuncheng Zhu Liangliang Chen Haifeng Ji Maomao Xi Yiru Fang Yi Li 

机构地区：[1]Shanghai Mental Health Center,Shanghai Jiao Tong University School of Medicine,Shanghai 200030,China [2]Shanghai Changning Mental Health Center(Affiliated to East China Normal University),Shanghai 200335,China [3]Institute of Burns,Tongren Hospital of Wuhan University(Wuhan Third Hospital),Wuhan 430000,China [4]Affiliated Wuhan Mental Health Center,Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430012,China [5]CAS Center for Excellence in Brain Science and Intelligence Technology,Shanghai 200031,China [6]Shanghai Key Laboratory of Psychotic Disorders,Shanghai 201108,China

出　　处：《Neuroscience Bulletin》2020年第3期299-302,共4页神经科学通报（英文版）

基　　金：the National Key Research and Development Program of China(2016YFC1307100);the National Natural Science Foundation of China(81771465 and 81930033);the Research Project of Changning District Health Committee of Shanghai Municipality,China(20194Y013).

摘　　要：Dear Editor,Since the middle of December 2019,human-to-human transmission of novel coronavirus pneumonia(NCP,also called COVID-19)has occurred among close contacts[1].After the outbreak on January 21,2020,it was swiftly included among the Class B infectious diseases stipulated in the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases,and measures for prevention and control of Class A infectious diseases were adopted.At 21:27 on February 12,2020,the China News Network updated information to include epidemic data from the National Health Commission and official channels in Hong Kong,Macao,and Taiwan regions:the highest death rate was in Wuhan City(Table 1).Overload of inpatients at hospitals may play a negative role in the overall therapeutic effect and contribute to the death rate.

关 键 词：PREVENTION TAIWAN measures 

分 类 号：R749[医药卫生—神经病学与精神病学] R563.1[医药卫生—临床医学]